Excellgene Overview

  • Founded
  • 2001

Founded
  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 1

Excellgene General Information

Description

Developer of a synthetic protein intended to provide protein expressions for complex projects. The company's products are cultivated in animal cells and simple antibodies through clone screening for identification of optimal match of physiology and genetics for highest yield, enabling the biopharma industry to scale-up transient gene expression in non-instrumented bioreactors.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Primary Office
  • Route de l'Ile-aux-Bois 1A
  • 1870 Monthey
  • Switzerland
+41 024 000 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Excellgene Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 11-Nov-2014 Completed Generating Revenue
To view Excellgene’s complete valuation and funding history, request access »

Excellgene Patents

Excellgene Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3914614-A1 Methods of producing and using recombinant alpha 1-antitrypsin (aat) and compositions thereof Pending 24-Jan-2019 00000000000
AU-2020211080-A1 Methods of producing and using recombinant alpha 1-antitrypsin (aat) and compositions thereof Pending 24-Jan-2019 00000000000
CA-3127750-A1 Methods of producing and using recombinant alpha 1-antitrypsin (aat) and compositions thereof Pending 24-Jan-2019 00000000000
EP-3843782-A1 Ebola vaccine compositions and methods of using same Pending 29-Aug-2018 0000000000
US-20210340185-A1 Ebola vaccine compositions and methods of using same Pending 29-Aug-2018 A61K39/12
To view Excellgene’s complete patent history, request access »

Excellgene Executive Team (5)

Name Title Board Seat Contact Info
Maria Wurm Chief Executive Officer
Sebastian Rheindorf-Zaorski Chief Strategy Officer
Florian Wurm Ph.D Co-Founder, Chairman & Chief Scientific Officer
George Hong Ph.D Chief Commercial Officer
Martin Schmid Chief Financial Officer
To view Excellgene’s complete executive team members history, request access »

Excellgene Board Members (1)

Name Representing Role Since
Florian Wurm Ph.D Excellgene Co-Founder, Chairman & Chief Scientific Officer 000 0000
To view Excellgene’s complete board members history, request access »

Excellgene Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Fondation The Ark Accelerator/Incubator 000 0000 000000 0
To view Excellgene’s complete investors history, request access »